McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
683.51
+2.99 (0.44%)
At close: Aug 27, 2025, 4:00 PM
683.60
+0.09 (0.01%)
After-hours: Aug 27, 2025, 7:02 PM EDT
McKesson Revenue
McKesson had revenue of $97.83B in the quarter ending June 30, 2025, with 23.39% growth. This brings the company's revenue in the last twelve months to $377.60B, up 20.35% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.
Revenue (ttm)
$377.60B
Revenue Growth
+20.35%
P/S Ratio
0.23
Revenue / Employee
$7,403,824
Employees
51,000
Market Cap
85.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MCK News
- 21 days ago - McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Mckesson lifts annual profit forecast on robust demand for specialty drugs - Reuters
- 21 days ago - McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
- 4 weeks ago - McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share - Business Wire
- 4 weeks ago - McKesson Defied The Doubters (Including Me)--And Could Do It Again - Seeking Alpha
- 5 weeks ago - Our Top 10 High Growth Dividend Stocks - July 2025 - Seeking Alpha
- 6 weeks ago - McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive - Business Wire
- 2 months ago - McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date - Business Wire